Key result
Timp-1 deficiency protects mice from H1N1-induced weight loss, mortality, and lung injury.
Why the study?
Does Timp-1 deficiency protect against weight loss, mortality, and lung injury in mice infected with H1N1 influenza A virus?
Does Timp-1 deficiency protect against weight loss, mortality, and lung injury in mice infected with H1N1 influenza A virus?
TIMP-1 may serve as a novel therapeutic target for influenza A virus infection, as its deficiency protects against severe disease outcomes in mice.
Answers are grounded in this paper and cite their sources.
Should not change clinical practice; leaves open whether Timp-1 targeting translates to human influenza.
Our data strongly link tissue inhibitor of metalloproteinases-1 (TIMP-1) to influenza A virus (IAV) pathogenesis. TIMP-1 is highly increased in PDGFRα-lineage cells during IAV infection. Transforming growth factor-β (TGF-β) induces TIMP-1 during lipofibroblast (lipoFB)-to- myofibroblast (myoFB) transdifferentiation. Timp-1 deficiency protects mice from H1N1 IAV-induced weight loss, mortality, and lung injury. TIMP-1 may be a novel therapeutic target for IAV infection.
No takes yet. Share an insight, caveat, or question.
Dutta et al. (2024) studied Influenza A virus (IAV) infection. Timp-1 deficiency was evaluated on Weight loss, mortality, and lung injury. Timp-1 deficiency protected mice from H1N1 influenza A virus-induced weight loss, mortality, and lung injury.
Synapse has enriched 10 related papers. Consider them for comparative context: